Yuhui Tan

483 total citations
20 papers, 363 citations indexed

About

Yuhui Tan is a scholar working on Molecular Biology, Epidemiology and Genetics. According to data from OpenAlex, Yuhui Tan has authored 20 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Epidemiology and 5 papers in Genetics. Recurrent topics in Yuhui Tan's work include Autophagy in Disease and Therapy (6 papers), Virus-based gene therapy research (4 papers) and Sirtuins and Resveratrol in Medicine (4 papers). Yuhui Tan is often cited by papers focused on Autophagy in Disease and Therapy (6 papers), Virus-based gene therapy research (4 papers) and Sirtuins and Resveratrol in Medicine (4 papers). Yuhui Tan collaborates with scholars based in China, Hong Kong and United States. Yuhui Tan's co-authors include Biaoyan Du, Jianyong Xiao, Kun Wang, Yingya Wu, Guang‐Xian Zhang, Yujuan Zhan, Xiaodong Liu, Bonan Chen, Ting Yin and Idy H. T. Ho and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Yuhui Tan

20 papers receiving 361 citations

Peers

Yuhui Tan

EPIDE

ONCOL

IMMUN

Chia‐Yao Shen Taiwan

Fu‐Gang Duan China

Fatima Rizvi United States

Natalia Lisiak Poland

Shengjun Fan China

Qiang Qiu China

Xinhui Kou China

Ajeet Kumar Verma India

Xianjun Yu China

Chia‐Yao Shen Taiwan

Yuhui Tan

218 ×0.9

47 ×0.7

EPIDE

68 ×1.3

47 ×1.0

ONCOL

36 ×0.9

IMMUN

Citations per year, relative to Yuhui Tan Yuhui Tan (= 1×) peers Chia‐Yao Shen

Countries citing papers authored by Yuhui Tan

Since Specialization

Citations

This map shows the geographic impact of Yuhui Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuhui Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuhui Tan more than expected).

Fields of papers citing papers by Yuhui Tan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuhui Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuhui Tan. The network helps show where Yuhui Tan may publish in the future.

Co-authorship network of co-authors of Yuhui Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Yuhui Tan. A scholar is included among the top collaborators of Yuhui Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuhui Tan. Yuhui Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Luo, He, Dan Chen, Jing Zhou, et al.. (2025). Cepharanthine Enhances MHC-I Antigen Presentation and Anti-Tumor Immunity in Melanoma via Autophagy Inhibition. Cells. 14(16). 1231–1231. 1 indexed citations

Tan, Yuhui, Marion Weber‐Boyvat, Jie Zheng, et al.. (2023). Oculocerebrorenal syndrome of Lowe (OCRL) controls leukemic T-cell survival by preventing excessive PI(4,5)P2 hydrolysis in the plasma membrane. Journal of Biological Chemistry. 299(6). 104812–104812. 3 indexed citations

Liao, Yuan, Yujiao Liu, Yue Song, et al.. (2023). Identification of Fangjihuangqi Decoction as a late-stage autophagy inhibitor with an adjuvant anti-tumor effect against non-small cell lung cancer. Chinese Medicine. 18(1). 68–68. 2 indexed citations

Zhan, Yujuan, Bonan Chen, Chengxi Li, et al.. (2022). Berbamine Hydrochloride inhibits lysosomal acidification by activating Nox2 to potentiate chemotherapy-induced apoptosis via the ROS-MAPK pathway in human lung carcinoma cells. Cell Biology and Toxicology. 39(4). 1297–1317. 14 indexed citations

Li, Hong, Guangxian Zhang, Yingya Wu, et al.. (2020). Synergistic inhibitory effect of resveratrol and TK/GCV therapy on melanoma cells. Journal of Cancer Research and Clinical Oncology. 146(6). 1489–1499. 10 indexed citations

Chen, Xiaona, Yan‐Hong He, Wenjun Fu, et al.. (2020). Histone Deacetylases (HDACs) and Atherosclerosis: A Mechanistic and Pharmacological Review. Frontiers in Cell and Developmental Biology. 8. 581015–581015. 31 indexed citations

Wang, Kun, Xiaodong Liu, Idy H. T. Ho, et al.. (2020). Hederagenin potentiated cisplatin- and paclitaxel-mediated cytotoxicity by impairing autophagy in lung cancer cells. Cell Death and Disease. 11(8). 611–611. 66 indexed citations

Li, Hong, Haiyan Du, Guang‐Xian Zhang, et al.. (2019). Curcumin plays a synergistic role in combination with HSV-TK/GCV in inhibiting growth of murine B16 melanoma cells and melanoma xenografts. PeerJ. 7. e7760–e7760. 12 indexed citations

Wang, Kun, Bonan Chen, Ting Yin, et al.. (2019). N-Methylparoxetine Blocked Autophagic Flux and Induced Apoptosis by Activating ROS-MAPK Pathway in Non-Small Cell Lung Cancer Cells. International Journal of Molecular Sciences. 20(14). 3415–3415. 29 indexed citations

10.

Zhan, Yujuan, Kun Wang, Qiao Li, et al.. (2018). The Novel Autophagy Inhibitor Alpha-Hederin Promoted Paclitaxel Cytotoxicity by Increasing Reactive Oxygen Species Accumulation in Non-Small Cell Lung Cancer Cells. International Journal of Molecular Sciences. 19(10). 3221–3221. 43 indexed citations

11.

Xiao, Jianyong, Xiaolan Wang, Yingya Wu, et al.. (2018). Synergistic effect of resveratrol and HSV-TK/GCV therapy on murine hepatoma cells. Cancer Biology & Therapy. 20(2). 183–191. 15 indexed citations

12.

Tan, Yuhui, et al.. (2017). Resveratrol enhances the radiosensitivity of nasopharyngeal carcinoma cells by downregulating E2F1. Oncology Reports. 37(3). 1833–1841. 36 indexed citations

13.

Tan, Yuhui, et al.. (2016). miR-34b inhibits nasopharyngeal carcinoma cell proliferation by targeting ubiquitin-specific peptidase 22. OncoTargets and Therapy. 9. 1525–1525. 9 indexed citations

14.

Zhang, Guang‐Xian, Xiancheng Zeng, Juan Liu, et al.. (2016). Dioscin suppresses hepatocellular carcinoma tumor growth by inducing apoptosis and regulation of TP53, BAX, BCL2 and cleaved CASP3. Phytomedicine. 23(12). 1329–1336. 51 indexed citations

15.

Xiao, Jianyong, Guang‐Xian Zhang, Bin Li, et al.. (2016). Dioscin augments HSV-tk-mediated suicide gene therapy for melanoma by promoting connexin-based intercellular communication. Oncotarget. 8(1). 798–807. 21 indexed citations

16.

Zhang, Yong, Zhenxin Zhang, Baiyu Yang, et al.. (2014). Effects of Antiplatelet Agents on Functional Outcome and Cognitive Status in Patients with Acute Ischemic Stroke. International journal of gerontology. 8(4). 189–192. 3 indexed citations

17.

Xiao, Jianyong, Guang‐Xian Zhang, Pengxiang Qiu, et al.. (2013). Tanshinone IIA Increases the Bystander Effect of Herpes Simplex Virus Thymidine Kinase/Ganciclovir Gene Therapy via Enhanced Gap Junctional Intercellular Communication. PLoS ONE. 8(7). e67662–e67662. 14 indexed citations

18.

Du, Biaoyan, Yurong Guo, Yi Hua, Yuhui Tan, & Yingya Wu. (2013). [The preliminary research on the gap junction mechanisms for synergistic effects of liuwei di-huang pill containing serum on suicide gene therapy of melanoma].. PubMed. 33(5). 651–8. 1 indexed citations

19.

Hua, Yi, et al.. (2009). Investigate the mechanism of Liuwei Dihuang Bolus enhancing hepatocarcinoma suicide gene therapy from Cx26.. Zhonghua zhongyiyao zazhi. 24(9). 1200–1204. 1 indexed citations

20.

Du, Biaoyan, et al.. (2004). Retroviral Vector Introduced in the Construction of HSV1-tk/GCV Antitumor Suicide-gene Therapeutic System. Guangzhou Zhongyiyao Daxue xuebao. 21(5). 395–398. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact